Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer
- Resource Type
- Article
- Authors
- Moore, Kathleen N.; Birrer, Michael J.; Marsters, Jim; Wang, Yulei; Choi, YounJeong; Royer-Joo, Stephanie; Lemahieu, Vanessa; Armstrong, Katy; Cordova, Julie; Samineni, Divya; Schuth, Eva; Vaze, Anjali; Maslyar, Daniel; Humke, Eric W.; Hamilton, Erika P.; Liu, Joyce F.
- Source
- In Gynecologic Oncology September 2020 158(3):631-639
- Subject
- Language
- ISSN
- 0090-8258